A Brief Review of Drug Discovery Research for Human African Trypanosomiasis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Medicinal Chemistry

• Publication date

  2017-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/0929867324666170120160034PMID 28117003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tyrosol and hydroxytyrosol derivatives as antitrypanosomal and antileishmanial agents.

  2016cited by this paper
• Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense.

  2016cited by this paper
• 5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase Inhibitors

  2016cited by this paper
• Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness

  2016cited by this paper
• Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode

  2015cited by this paper
• Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites.

  2015cited by this paper
• Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis

  2015cited by this paper
• 6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors.

  2015cited by this paper
• Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei

  2015cited by this paper
• 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.

  2015cited by this paper
• Dipeptidyl Enoates As Potent Rhodesain Inhibitors That Display a Dual Mode of Action

  2015cited by this paper
• Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis.

  2014cited by this paper
• Treatment options for second-stage gambiense human African trypanosomiasis

  2014cited by this paper
• The Design and Synthesis of Potent and Selective Inhibitors of Trypanosoma brucei Glycogen Synthase Kinase 3 for the Treatment of Human African Trypanosomiasis

  2014cited by this paper
• Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects

  2014cited by this paper
• 1,2-Substituted 4-(1H)-Quinolones: Synthesis, Antimalarial and Antitrypanosomal Activities in Vitro

  2014cited by this paper
• The discovery of first-in-class drugs: origins and evolution

  2014cited by this paper
• In Vitro and In Vivo Evaluation of 28DAP010, a Novel Diamidine for Treatment of Second-Stage African Sleeping Sickness

  2014cited by this paper
• Semisynthesis of salviandulin E analogues and their antitrypanosomal activity.

  2014cited by this paper
• Lead Optimization of a Pyrazole Sulfonamide Series of Trypanosoma bruceiN-Myristoyltransferase Inhibitors: Identification and Evaluation of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human African Trypanosomiasis

  2014cited by this paper
• Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi.

  2014cited by this paper
• Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.

  2014cited by this paper
• Antitrypanosomal structure-activity-relationship study of synthetic cynaropicrin derivatives.

  2014cited by this paper
• Epidemiology of human African trypanosomiasis

  2014cited by this paper
• Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase.

  2014cited by this paper
• The journey towards elimination of gambiense human African trypanosomiasis: not far, nor easy

  2014cited by this paper
• First WHO Meeting of Stakeholders on Elimination of Gambiense Human African Trypanosomiasis

  2014cited by this paper
• Evaluating 5-Nitrofurans as Trypanocidal Agents

  2013cited by this paper
• Pharmacophore identification of ascofuranone, potent inhibitor of cyanide-insensitive alternative oxidase of Trypanosoma brucei.

  2013cited by this paper
• In Silico Prediction and Experimental Evaluation of Furanoheliangolide Sesquiterpene Lactones as Potent Agents against Trypanosoma brucei rhodesiense

  2013cited by this paper
• Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives.

  2013cited by this paper
• Pharmacokinetics, Trypanosoma brucei gambiense Efficacy, and Time of Drug Action of DB829, a Preclinical Candidate for Treatment of Second-Stage Human African Trypanosomiasis

  2013cited by this paper
• Drug discovery and human African trypanosomiasis: a disease less neglected?

  2013cited by this paper
• From On-Target to Off-Target Activity: Identification and Optimisation of Trypanosoma brucei GSK3 Inhibitors and Their Characterisation as Anti-Trypanosoma brucei Drug Discovery Lead Molecules

  2013cited by this paper
• Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.

  2013cited by this paper
• 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.

  2013cited by this paper
• Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis.

  2013cited by this paper
• Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.

  2013cited by this paper
• The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing.

  2013cited by this paper
• Novel naphthoquinone derivatives: synthesis and activity against human African trypanosomiasis.

  2013cited by this paper
• Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.

  2013cited by this paper
• Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign

  2012cited by this paper
• New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents.

  2012cited by this paper
• Human African trypanosomiasis in non-endemic countries (2000-2010).

  2012cited by this paper
• Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness).

  2012cited by this paper
• Cynaropicrin: The First Plant Natural Product with In Vivo Activity against Trypanosoma brucei

  2012cited by this paper
• Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization.

  2012cited by this paper
• Cinnamoylphenethyl Amides from Polygonum hyrcanicum Possess Anti-Trypanosomal Activity

  2012cited by this paper
• Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.

  2011cited by this paper
• 1-Aryl-4-nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis.

  2011cited by this paper
• Selective Inhibitors of Methionyl-tRNA Synthetase Have Potent Activity against Trypanosoma brucei Infection in Mice

  2011cited by this paper
• Sleeping sickness.

  2011cited by this paper
• How were new medicines discovered?

  2011cited by this paper
• SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis

  2011cited by this paper
• The Human African Trypanosomiasis Control and Surveillance Programme of the World Health Organization 2000–2009: The Way Forward

  2011cited by this paper
• N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness

  2010cited by this paper
• Human African trypanosomiasis

  2010cited by this paper
• Potential new drugs for human African trypanosomiasis: some progress at last

  2010cited by this paper
• Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness

  2010cited by this paper
• The development of drugs for treatment of sleeping sickness: a historical review

  2010cited by this paper
• Application of monoclonal antibodies to measure metabolism of an anti‐trypanosomal compound in vitro and in vivo

  2010cited by this paper
• Quantitative Structure − Antiprotozoal Activity Relationships of Sesquiterpene Lactones †

  2009cited by this paper
• Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.

  2009cited by this paper
• Improved Tricyclic Inhibitors of Trypanothione Reductase by Screening and Chemical Synthesis

  2009cited by this paper
• Effect of ruthenium complexation on trypanocidal activity of 5-nitrofuryl containing thiosemicarbazones.

  2009cited by this paper
• The continuing problem of human African trypanosomiasis (sleeping sickness)

  2008cited by this paper
• Estimates of the duration of the early and late stage of gambiense sleeping sickness

  2008cited by this paper
• A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes

  2008cited by this paper
• Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas’ disease

  2008cited by this paper
• The history of African trypanosomiasis

  2008cited by this paper
• Synthesis of a small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing anti-trypanosomal and anti-leishmanial activity.

  2008cited by this paper
• Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets.

  2006cited by this paper
• Human African trypanosomiasis–neurological aspects

  2006cited by this paper
• Human African trypanosomiasis of the CNS: current issues and challenges.

  2004cited by this paper
• Myristoyl-CoA:Protein N-Myristoyltransferase, an Essential Enzyme and Potential Drug Target in Kinetoplastid Parasites*

  2003cited by this paper
• Nitroheterocyclic drugs with broad spectrum activity

  2003cited by this paper
• Nifedipine facilitates neurotransmitter release independently of calcium channels

  2003cited by this paper
• The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice.

  2003cited by this paper
• Transporters in African trypanosomes: role in drug action and resistance.

  2001cited by this paper
• Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda.

  1997cited by this paper
• Flunitrazepam: A Review of its Pharmacological Properties and Therapeutic Use

  1980cited by this paper
• Trypanocidal Activity of Antitumor Antibiotics and Other Metabolic Inhibitors

  1978cited by this paper

• In vivo Antitrypanosomal Activity of Ethanol Leaf and Root Extracts of Senna siamea on Trypanosoma brucei brucei Infected Albino Mice

  2026cites this paper
• Kinetoplastid diseases: insights into the mechanisms of drug action and resistance for novel drug discovery

  2025cites this paper
• Design, synthesis and biological evaluations of quinolone amides against African trypanosomiasis with improved solubility.

  2023cites this paper
• Parasite metalo-aminopeptidases as targets in human infectious diseases.

  2023cites this paper
• Targeted protein degradation might present a novel therapeutic approach in the fight against African trypanosomiasis

  2023cites this paper
• GNPS-guided discovery of xylacremolide C and D, evaluation of their putative biosynthetic origin and bioactivity studies of xylacremolide A and B

  2021cites this paper
• Protein Lactylation Critically Regulates Energy Metabolism in the Protozoan Parasite Trypanosoma brucei

  2021cites this paper
• Synthesis and evaluation of tetrahydroisoquinoline derivatives against Trypanosoma brucei rhodesiense.

  2021cites this paper
• Taking a re-look at cap-binding signatures of the mRNA cap-binding protein eIF4E orthologues in trypanosomatids

  2020cites this paper
• Modular Solid-Phase Synthesis of Antiprotozoal Barnesin Derivatives.

  2020cites this paper
• Recent Advances in the Development of Broad-Spectrum Antiprotozoal Agents.

  2020cites this paper
• The proteasome as a target for protozoan parasites

  2019cites this paper
• Cell death pathways in pathogenic trypanosomatids: lessons of (over)kill

  2019cites this paper
• Trypanosoma brucei Interaction with Host: Mechanism of VSG Release as Target for Drug Discovery for African Trypanosomiasis

  2019influential citation
• An evaluation of the antiparasitic activities of a novel natural product and open-access Pathogen Box libraries

  2019cites this paper
• Benzimidazole inhibitors of the major cysteine protease of Trypanosoma brucei.

  2019cites this paper
• Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections

  2019cites this paper
• Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48

  2018cites this paper
• Human Kinetoplastid Protozoan Infections: Where Are We Going Next?

  2018cites this paper
• G-Quadruplex Identification in the Genome of Protozoan Parasites Points to Naphthalene Diimide Ligands as New Antiparasitic Agents

  2018cites this paper
• 3-Hydroxynaphthalene-2-carboxanilides and their antitrypanosomal activity

  2018cites this paper
• Antiprotozoal, antiviral and cytotoxic properties of the Nigerian Mushroom, Hypoxylon fuscum Pers. Fr. (Xylariaceae)

  2018cites this paper
• Acidic and Evaluation

  2018cites this paper
• Antimicrobial and antiprotozoal activities of twenty-four Nigerian medicinal plant extracts

  2018cites this paper
• Semisynthesis of ω-Hydroxyalkylcarbonate Derivatives of Hydroxytyrosol as Antitrypanosome Agents.

  2018cites this paper
• Targeting Trypanosoma brucei FPPs by fragment- based drug discovery

  2017cites this paper
• Structural Characterization of Acidic M17 Leucine Aminopeptidases from the TriTryps and Evaluation of Their Role in Nutrient Starvation in Trypanosoma brucei

  2017cites this paper